VT News
Kevin Hartman

Kevin Hartman

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Helicopter crashes during power line work, killing two on board and prompting river closure as investigation begins.
  • Chicago approves historic 2025 river swim event, raising funds for ALS research and youth swim education.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Helicopter crashes during power line work, killing two on board and prompting river closure as investigation begins.
  • Chicago approves historic 2025 river swim event, raising funds for ALS research and youth swim education.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Kevin Hartman

Top Topics

Trending in U.S.

World

Sport